207 related articles for article (PubMed ID: 20578449)
1. Toxoplasmosis in HIV/AIDS: a living legacy.
Nissapatorn V
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1158-78. PubMed ID: 20578449
[TBL] [Abstract][Full Text] [Related]
2. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasmosis in HIV/AIDS patients: a current situation.
Nissapatorn V; Lee C; Quek KF; Leong CL; Mahmud R; Abdullah KA
Jpn J Infect Dis; 2004 Aug; 57(4):160-5. PubMed ID: 15329448
[TBL] [Abstract][Full Text] [Related]
4. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses.
Hoffmann C; Ernst M; Meyer P; Wolf E; Rosenkranz T; Plettenberg A; Stoehr A; Horst HA; Marienfeld K; Lange C
Clin Microbiol Infect; 2007 May; 13(5):510-5. PubMed ID: 17298486
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria.
Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
Nig Q J Hosp Med; 2010; 20(3):104-7. PubMed ID: 21033315
[TBL] [Abstract][Full Text] [Related]
6. Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.
Ghosn J; Paris L; Ajzenberg D; Carcelain G; Dardé ML; Tubiana R; Bossi P; Bricaire F; Katlama C
Clin Infect Dis; 2003 Oct; 37(7):e112-4. PubMed ID: 13130422
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
8. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
9. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient.
Contini C
Parassitologia; 2008 Jun; 50(1-2):45-50. PubMed ID: 18693556
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
[TBL] [Abstract][Full Text] [Related]
12. Recognition and management of toxoplasmosis.
Heitman BB; Irizarry AF
Nurse Pract; 1997 Sep; 22(9):75, 79-82, 85-6 passim. PubMed ID: 9314166
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
14. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection.
Ho YC; Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SC
J Microbiol Immunol Infect; 2008 Oct; 41(5):386-92. PubMed ID: 19122919
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.
Abgrall S; Rabaud C; Costagliola D;
Clin Infect Dis; 2001 Nov; 33(10):1747-55. PubMed ID: 11595976
[TBL] [Abstract][Full Text] [Related]
17. IgG anti-toxoplasma antibodies among asymptomatic HIV-infected patients in Marrakesh-Morocco.
Addebbous A; Adarmouch L; Tali A; Laboudi M; Amine M; Aajly L; Rhajaoui M; Chabaa L; Zougaghi L
Acta Trop; 2012 Jul; 123(1):49-52. PubMed ID: 22425678
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary complications in patients with AIDS].
Oka S
Kekkaku; 2002 Jan; 77(1):37-40. PubMed ID: 11855078
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of toxoplasmosis in HIV(+)/AIDS patients in Iran.
Mohraz M; Mehrkhani F; Jam S; SeyedAlinaghi S; Sabzvari D; Fattahi F; Jabbari H; Hajiabdolbaghi M
Acta Med Iran; 2011; 49(4):213-8. PubMed ID: 21713730
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma gondii antibody in HIV-infected persons.
Sukthana Y; Chintana T; Lekkla A
J Med Assoc Thai; 2000 Jun; 83(6):681-4. PubMed ID: 10932497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
